Evidence map›Paper›PMID 29855385›Full record

ArticleCritical care (London, England)2018

Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS).

Navin P Boeddha, Luregn J Schlapbach, Gertjan J Driessen, Jethro A Herberg, Irene Rivero-Calle, Miriam Cebey-López, Daniela S Klobassa, Ria Philipsen, Ronald de Groot, David P Inwald and 16 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Critical care (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Journal of preventive medicine and hygiene · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. 5-HTJournal of advanced research · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 17 institutions in 7 countries.

Navin P BoeddhaIntensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
Luregn J SchlapbachFaculty of Medicine, The University of Queensland, St Lucia Queensland, Brisbane, 4072, Australia.
Gertjan J DriessenDepartment of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
Jethro A HerbergSection of Pediatrics, Imperial College London, Level 2, Faculty Building South Kensington Campus, London, SW7 2AZ, UK.
Irene Rivero-CalleTranslational Pediatrics and Infectious Diseases Section- Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Travesía da Choupana, 15706, Santiago de Compostela, Spain.
Miriam Cebey-LópezGenetics- Vaccines- Infectious Diseases and Pediatrics research group GENVIP, Health Research Institute of Santiago IDIS/SERGAS, Travesía da Choupana, 15706, Santiago de Compostela, Spain.
Daniela S KlobassaDepartment of General Paediatrics, Medical University of Graz, Auenbruggerplatz 34/2, A-8036, Graz, Austria.
Ria PhilipsenRadboudumc Technology Center Clinical Studies, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
Ronald de GrootSection of Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
David P InwaldDepartment of Paediatrics, Faculty of Medicine, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Simon NadelDepartment of Paediatrics, Faculty of Medicine, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Stéphane PaulusDivision of Paediatric Infectious Diseases, Alder Hey Children's NHS Foundation Trust, Eaton Rd, Liverpool, L12 2AP, UK.
Eleanor PinnockMicropathology Ltd, University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry, CV4 7EZ, UK.
Fatou SeckaMedical research Council Unit, Atlantic Boulevard, Fajara, P. O. Box 273, Banjul, The Gambia.
Suzanne T AndersonMedical research Council Unit, Atlantic Boulevard, Fajara, P. O. Box 273, Banjul, The Gambia.
Rachel S AgbekoDepartment of Paediatric Intensive Care, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Victoria Wing, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.
Christoph BergerDivision of Infectious Diseases and Hospital Epidemiology, and Children's Research Center, University Children's Hospital Zurich, Steinwiesenstrasse 75, 8032, Zurich, Switzerland.
Colin G FinkMicropathology Ltd, University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry, CV4 7EZ, UK.
Enitan D CarrolInstitute of Infection & Global Health, University of Liverpool, 8 West Derby St, Liverpool, L7 3EA, UK.
Werner ZenzDepartment of General Paediatrics, Medical University of Graz, Auenbruggerplatz 34/2, A-8036, Graz, Austria.
Michael LevinSection of Pediatrics, Imperial College London, Level 2, Faculty Building South Kensington Campus, London, SW7 2AZ, UK.
Michiel van der FlierRadboudumc Technology Center Clinical Studies, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
Federico Martinón-TorresTranslational Pediatrics and Infectious Diseases Section- Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Travesía da Choupana, 15706, Santiago de Compostela, Spain.
Jan A HazelzetDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands. j.a.hazelzet@erasmusmc.nl.
Marieke EmontsInstitute of Cellular Medicine, Newcastle University, 4th Floor, William Leech Building, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
EUCLIDS consortium
Erasmus MC - Sophia Children’s Hospital · NLImperial College Healthcare NHS Trust · GBImperial College London · GBMedical University of Graz · ATMRC Unit the Gambia · GMRadboud University Nijmegen · NLUniversity of Liverpool · GBUniversity of Warwick Science Park · GBComplejo Hospitalario Universitario de Santiago · ESErasmus MC · NLInstituto de Investigación Sanitaria de Santiago · ESMater Research · AUNewcastle University · GBNIHR Newcastle Biomedical Research Centre · GBRadboud University Medical Center · NLServicio Gallego de Salud · ESUniversity Children's Hospital Zurich · CH

Funding

Bangerter Foundation N/AEuropean Seventh Framework Programme for Research and Technological Development (FP7) 279185Foundation for the Health of Children and Adolescents N/ANational Institute for Health Research Newcastle Biomedical Research Centre N/ASwiss National Science Foundation 342730_153158/1Swiss Society of Intensive Care N/AVinetum and Borer Foundation N/A
6 · The paper itself

Abstract

backgroundSepsis is one of the main reasons for non-elective admission to pediatric intensive care units (PICUs), but little is known about determinants influencing outcome. We characterized children admitted with community-acquired sepsis to European PICUs and studied risk factors for mortality and disability.

methodsData were collected within the collaborative Seventh Framework Programme (FP7)-funded EUCLIDS study, which is a prospective multicenter cohort study aiming to evaluate genetic determinants of susceptibility and/or severity in sepsis. This report includes 795 children admitted with community-acquired sepsis to 52 PICUs from seven European countries between July 2012 and January 2016. The primary outcome measure was in-hospital death. Secondary outcome measures were PICU-free days censured at day 28, hospital length of stay, and disability. Independent predictors were identified by multivariate regression analysis.

resultsPatients most commonly presented clinically with sepsis without a source (n = 278, 35%), meningitis/encephalitis (n = 182, 23%), or pneumonia (n = 149, 19%). Of 428 (54%) patients with confirmed bacterial infection, Neisseria meningitidis (n = 131, 31%) and Streptococcus pneumoniae (n = 78, 18%) were the main pathogens. Mortality was 6% (51/795), increasing to 10% in the presence of septic shock (45/466). Of the survivors, 31% were discharged with disability, including 24% of previously healthy children who survived with disability. Mortality and disability were independently associated with S. pneumoniae infections (mortality OR 4.1, 95% CI 1.1-16.0, P = 0.04; disability OR 5.4, 95% CI 1.8-15.8, P < 0.01) and illness severity as measured by Pediatric Index of Mortality (PIM2) score (mortality OR 2.8, 95% CI 1.3-6.1, P < 0.01; disability OR 3.4, 95% CI 1.8-6.4, P < 0.001).

conclusionsDespite widespread immunization campaigns, invasive bacterial disease remains responsible for substantial morbidity and mortality in critically ill children in high-income countries. Almost one third of sepsis survivors admitted to the PICU were discharged with some disability. More research is required to delineate the long-term outcome of pediatric sepsis and to identify interventional targets. Our findings emphasize the importance of improved early sepsis-recognition programs to address the high burden of disease.

Indexed as

AdolescentAnalysis of VarianceChildChild, PreschoolChi-Square DistributionCohort StudiesCommunity-Acquired InfectionsEuropeFemaleHumansInfantIntensive Care Units, PediatricMaleProspective StudiesSepsisStatistics, NonparametricBacteremiaMeningococcal infectionsMorbidityMortalityPneumococcal infections

Identifiers

PMID29855385
PMCPMC5984383
OpenAlexW2807143291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.